Important Safety Information Prescribing Information For Healthcare Professionals
Home About Low T  Do You Have Low T? About AndroGel AndroGel Extras
Could you have Low T? Take the symptoms quiz to find out. Case Study
Welcome Back - Patient support program - Receive savings and support

All-new packet
The look is new but everything else is the same:

  • Same amount of gel
  • Same product strength
  • Same application method
Androgel 5g Packet

Androgel 2.5g Packet
Indication:
AndroGel is indicated for replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone.

Safety Information:
AndroGel must not be used if you have known or suspected prostate cancer or breast cancer (a rare condition for men). AndroGel must not be used by women who are pregnant, may become pregnant, or breastfeeding, as testosterone may cause fetal harm. The major risks of AndroGel include prostate enlargement, prostate cancer, and transfer of testosterone to others (including women and children). Transference can occur when vigorous skin-to-skin contact is made with the application site and can be minimized by washing your hands after application and covering the application site with clothing. The most common adverse events reported are skin irritation where gel is applied, breast development or tenderness, acne, prostate enlargement, changes in lab test results, and changes in urinary habits.

Remember, the information on this website does not take the place of the advice you get from your doctor or other health care professional. Always talk with your doctor if you have questions about AndroGel.
This information is intended for residents of the United States.
For international product information please visit us at http://www.solvay.com.
© 2007 Solvay Pharmaceuticals, Inc.
Marketed by Solvay PharmaceuticalsPartnership Prescription Assistance
Androgel
 
 
 
Close
Close